A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir

A group of Vanguard Community Health Centre doctors embarked on a Health System’s Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usu...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Junaid, Loftus, Izak, Vallie, Nabeelah, Whitmore, Richard B., Solomon, Gaironesa, Powell, Michelle, Mniki, Samela, Namane, Mosedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517760/
https://www.ncbi.nlm.nih.gov/pubmed/34636616
http://dx.doi.org/10.4102/phcfm.v13i1.3088
Descripción
Sumario:A group of Vanguard Community Health Centre doctors embarked on a Health System’s Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.

Ejemplares similares